Circulating Tumor Cell
We provide an ISO15189 medical laboratory service to physicians and clinical researchers investigating circulating tumor cells (CTCs) in cancer patients. Our capability is supported by an integrated system for efficient and reproducible enrichment, enumeration, and isolation highly pure CTCs. Such liquid biopsy is a precision tool for identifying and tracking cancer transformation and metastasis. It has significant clinical impact in cancer diagnosis, prognosis, treatment, and monitoring in the new era of personalized medicine.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An interpretative report of the CTC sample will be provided. | |
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
CytoQuest™ CR system, SCx™ spiral chamber, TBx™ tension balancer, HBx™ micromixer, and TCx™ thermal control are trademarks and pending patents of Abnova Corporation. Cell-Surface Vimentin (CSV) antibody is a pending MD Anderson patent which has been exclusively licensed to Abnova Corporation. mutaFISH™ is a pending trademark and patent of Abnova Corporation. |
||||||||||||||||||||||||||||||||||||||||
For any inquiry, please contact : OEM@abnova.com